Table 2 Protection of C57BL/6 mice immunized in a 2-shot regimen with the indicated P. berghei ANKA knockout lines against challenge with wild type P. berghei ANKA sporozoites or blood stages.

From: Protective efficacy and safety of liver stage attenuated malaria parasites

Exp.

Attenuated parasite line (P. berghei ANKA)

1st shot

2nd shot * (day14)

Challenge dose # (day of challenge)

Protected/challenged animals (pre-patency)

3

LISP2(–)

10.000

10.000

1.000 (d42)

1/4 (d 5.75)

   

1.000 (d42)

0/4 (d 3)

4

LISP2(–)

20.000

20.000

10.000 (d28)

8/8

uis3 (–)

20.000

20.000

10.000 (d28)

3/7 ** (8.75 d)

LISP2(–)/uis3(–)

20.000

20.000

10.000 (d28)

3/8 (8.6 d)

   

10.000 (d28)

0/4 (3.75 d)

  1. *Numbers of sporozoites for first boost at day 14; d0 corresponds to date of first shot.
  2. #Mice were challenged with PbANKA wild type sporozoites; day of challenge after prime in parentheses.
  3. **1 breakthrough infection after priming with 20.000 PbANKA uis3(–) sporozoites.